Abstract

BACKGROUND AND PURPOSEThe highly conserved tryptophan (W6.48) in transmembrane domain 6 of GPCRs has been shown to play a central role in forming an active conformation in response to agonist binding. We set out to characterize the effect of this mutation on the efficacy of two agonists at multiple signalling pathways downstream of the adenosine A3 receptor.EXPERIMENTAL APPROACHResidue W6.48 in the human adenosine A3 receptor fused to yellow fluorescent protein was mutated to phenylalanine and expressed in CHO-K1 cells containing a cAMP response element reporter gene. The effects on agonist-mediated receptor internalization were monitored by automated confocal microscopy and image analysis. Further experiments were carried out to investigate agonist-mediated ERK1/2 phosphorylation, inhibition of [3H]-cAMP accumulation and β-arrestin2 binding.KEY RESULTSNECA was able to stimulate agonist-mediated internalization of the W6.48F mutant receptor, while the agonist HEMADO was inactive. Investigation of other downstream signalling pathways indicated that G-protein coupling was impaired for both agonists tested. Mutation of W6.48F therefore resulted in differential effects on agonist efficacy, and introduced signalling pathway bias for HEMADO at the adenosine A3 receptor.CONCLUSIONS AND IMPLICATIONSInvestigation of the pharmacology of the W6.48F mutant of the adenosine A3 receptor confirms that this region is important in forming the active conformation of the receptor for stimulating a number of different signalling pathways and that mutations in this residue can lead to changes in agonist efficacy and signalling bias.

Highlights

  • GPCR are composed of seven transmembrane (TM) spanning α-helices and are responsible for translating signals from the extracellular milieu to intracellular responses

  • Data are normalized to basal and maximal internalization mediated by 10 μM NECA and each data point represent the mean ± SEM of three experiments performed in triplicate

  • The binding of an agonist to a GPCR leads to structural changes within the TM regions allowing activation of a

Read more

Summary

Introduction

GPCR are composed of seven transmembrane (TM) spanning α-helices and are responsible for translating signals from the extracellular milieu to intracellular responses. For the angiotensin II receptor, mutation of residues within the DRY motif at the bottom of TM helix 3 can result in the receptor no longer being able to activate G-protein signalling, but which is still internalized effectively in an agonist-dependent manner (Gaborik et al, 2003; Wei et al, 2003). Analysis of the purified thermostabilized turkey β1-adrenoceptor has indicated that a bent conformation of TM6 is required for the formation of the inactivating ‘ionic lock’ (Moukhametzianov et al, 2011) Movement around this kink is believed to be the basis for forming an active conformation of the GPCR that can stimulate intracellular signalling pathways. Further experiments were carried out to investigate agonist-mediated ERK1/2 phosphorylation, inhibition of [3H]-cAMP accumulation and β-arrestin binding

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.